Find Bill
Find Your Legislator
Legislative Deadlines
Nov. 17, 2017
RSS Feed Permanent URL -A +A

Minutes for HB2030 - Committee on Public Health and Welfare

Short Title

Pharmacist, pharmacy student or intern, administration of any vaccine to a person six years of age or older.

Minutes Content for Wed, Mar 15, 2017

Chairperson Schmidt called the meeting to order and opened the hearing on HB2030.

Norm Furse, Staff Revisor, gave an overview of the bill.

Representative John Eplee presented testimony in support of HB2030. His testimony stated that passage of this bill would allow pharmacists and pharmacy interns, with appropriate training, to begin vaccinating patients age 12 and older. (Attachment 1)

Alexandra Blasi testified in support of HB2030. She stated that additional availability  of vaccination offerings may increase the number of minors receiving vaccinations and therefore would have a positive impact on the costs of future healthcare-related expenditures in the form of preventing illness. (Attachment 2)

Ron Hein gave testimony in support of HB2030 stating that the bill will increase needed vaccines for patients and families that would otherwise not be immunized. (Attachment 3)

Dean Benton presented testimony in support of HB2030 as it would allow increased access for vaccines as well as increased convenience for Kansans to be vaccinated. (Attachment 4)

Sam Boyajian testified that passage of this bill would position pharmacists to "pick-up" the overflow of unvaccinated young patients that have resulted from overburdened physicians.  (Attachment 5)

Dr. Jody Reel stated that by allowing pharmacists to immunize adolescents it would increase access and awareness of immunizations. (Attachment 6)

Written testimony was submitted by:

Carolyn Gaughan, Kansas Academy of Family Physicians (Attachment 7)

Lis Houchen, National Association of Chain Drug Stores (Attachment 8)

Michael Smith, Walgreens (Attachment 9)

Dr. Dennis Cooley, Kansas Chapter of American Academy of Pediatrics (Attachment 10)

After questions were submitted by the Committee, the hearing on HB2030 was closed.